Ashkan Kalantary-Charvadeh

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Topics

Embryonic Stem Cells

Endoplasmic Reticulum

Idiopathic Pulmonary Fibrosis

Top Venues

Journal of cellular biochemistry

Chemical biology & drug design

Cell biochemistry and function

Journal of biochemical and molecular toxicology

This page only lists publications with an associated author ORCID identifier.

Publications

Ashkan Kalantary-Charvadeh, Saeed Nazari Soltan Ahmad, Somayeh Aslani, Mehdi Beyrami, Mehran Mesgari-Abbasi
β-lapachone protects against doxorubicin-induced hepatotoxicity through modulation of NAD + /SIRT-1/FXR/p-AMPK/NF-kB and Nrf2 signaling axis. Journal of biochemical and molecular toxicology (2023)
Parisa Fayyazpour, Effat Alizadeh, Vahid Hosseini, Ashkan Kalantary-Charvadeh, Mitra Niafar, Vahideh Sadra, Zahra Norouzi, Aysan Saebnazar, Amir Mehdizadeh, Masoud Darabi
Fatty acids of type 2 diabetic serum decrease the stemness properties of human adipose-derived mesenchymal stem cells. Journal of cellular biochemistry 123 (7) (2022)
Ashkan Kalantary-Charvadeh, Vahid Hosseini, Amir Mehdizadeh, Saeed Nazari Soltan Ahmad, Reza Rahbarghazi, Hojjatollah Nozad Charoudeh, Mohammad Nouri, Masoud Darabi
The porcupine inhibitor WNT974 provokes ectodermal lineage differentiation of human embryonic stem cells. Cell biochemistry and function 40 (4) (2022)
Ashkan Kalantary-Charvadeh, Vahid Hosseini, Amir Mehdizadeh, Masoud Darabi
Application of porcupine inhibitors in stem cell fate determination. Chemical biology & drug design 96 (4) (2020)